Can Sertraline Be Used With ARNI?
Yes, sertraline can be safely used with ARNI (sacubitril/valsartan) as there are no documented drug-drug interactions between these medications.
Evidence Base
The available evidence does not identify any contraindications or clinically significant interactions between sertraline (an SSRI antidepressant) and sacubitril/valsartan. The major drug interaction concerns with ARNI therapy are well-established and specific:
Absolute Contraindications for ARNI
ARNI must NOT be used with:
- ACE inhibitors - concomitant use or within 36 hours of the last ACE inhibitor dose is contraindicated due to severe angioedema risk 1, 2, 1
- Patients with history of angioedema - regardless of cause 1, 2, 3
The mechanism behind the ACE inhibitor contraindication is critical: both ACE and neprilysin break down bradykinin, and dual inhibition dramatically increases angioedema risk. This was demonstrated with omapatrilat (a combined neprilysin/ACE inhibitor) which showed a 3-fold increased angioedema risk and was terminated from development 1, 2.
Documented Drug Interactions with ARNI
The FDA label and cardiovascular guidelines identify specific interactions 4, 5:
- Statins: Sacubitril inhibits OATP1B1, OATP1B3, OAT1, and OAT3 transporters, potentially increasing atorvastatin levels by up to 2-fold. Lower statin doses may be considered 4
- Monitoring required for: Hypotension, hyperkalemia, and renal function changes when combined with other RAAS inhibitors or aldosterone antagonists 6
Why Sertraline Is Safe
Sertraline is not mentioned in:
- ACC/AHA/HFSA heart failure guidelines 1, 2, 1, 3
- Hypertension Canada guidelines 6
- FDA labeling for sacubitril/valsartan 5
- AHA drug-drug interaction statements 4
Sertraline's metabolism (primarily CYP2C19, CYP2D6, and CYP3A4) does not overlap with sacubitril/valsartan's minimal CYP450 metabolism 5. Sacubitril is metabolized to its active form LBQ657 by esterases, not cytochrome P450 enzymes.
Clinical Monitoring Recommendations
When using ARNI with any medication, monitor for:
- Blood pressure - hypotension is the most common ARNI adverse effect 1, 5
- Renal function - particularly in patients with baseline renal impairment 6, 5
- Potassium levels - hyperkalemia risk, especially with concurrent aldosterone antagonists 6
- Angioedema symptoms - rare but serious complication 1, 2
Common Pitfalls to Avoid
- Do not confuse ARNI with ACE inhibitors or ARBs - while valsartan is an ARB component, the combination drug has unique properties and contraindications
- Ensure 36-hour washout if switching from an ACE inhibitor to ARNI 1, 2
- Do not assume all cardiovascular drugs interact - the interaction profile is specific and well-defined
The combination of sertraline and ARNI requires no special precautions beyond standard monitoring for each medication individually.